Clinical Trial

Glaucoma Rehabilitation Using ElectricAI Transcranial Stimulation (GREAT) - Randomized Controlled Trial Using Combined Perceptual Learning and Transcranial Electrical Stimulation for Vision Enhancement

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Glaucoma is a complex disease that can result in progressive vision loss. It is the second leading cause of blindness, accounting for 23% of permanent blindness in Hong Kong. There are no treatments that restore vision lost to glaucoma. However, recent studies have shown that vision can be improved by perceptual learning (PL) and transcranial electrical stimulation (tES). This study will examine the effect of perceptual learning and tES on improving quality of life, visual function and functional performance in patients with peripheral field loss due to glaucoma. It is phase 2 of Glaucoma Rehabilitation Using ElectricAI Transcranial Stimulation (GREAT) project.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-16; most recent amendment 2024-10-28.
Status change: Not Yet Recruiting → Recruiting 2023-08-06
Trial Details
NCT Number NCT05874258
Lead Sponsor The Hong Kong Polytechnic University
Collaborators: The University of Hong Kong, University of Waterloo, University of Magdeburg
Conditions Glaucoma
Enrollment 144 participants
Start Date 2023-05-15
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-29